AI & Machine Learning

IEEE-USA is launching BiG Thinkers, a new event uniting leaders from Disney, OpenAI, and Pixar to cultivate creativity and leadership in tech professionals.

Documo’s award-winning AI platform is turning the tide on healthcare's reliance on fax, automating paperwork to reduce staff burnout and improve patient care.

The Jewish Theological Seminary appoints engagement expert Rabbi Mike Uram, signaling a strategic shift to modernize and expand its reach in a changing world.

BsStrategy's latest platform update signals a major shift in AI finance, where robust infrastructure and risk control are eclipsing the hunt for magic algorithms.

Two major data providers have launched the Sports Data Exchange, an open standard aiming to solve the industry's biggest data headache and unlock innovation.

With fresh capital, the Swedish biotech is scaling its revolutionary platform that decodes cellular communication, fueling a major US expansion.

A new partnership delivers a domestically-made BESS control system, tackling strict federal regulations and securing the US clean energy supply chain.

A strategic merger between Tenet’s AI platform and Crown’s air freight legacy aims to create a unified, end-to-end solution for North American carriers.

A Boston biotech is using AI and targeted mRNA to program cells inside the body, aiming to make complex CAR T treatments safer and universally accessible.

As AI coding tools proliferate, a new solution aims to secure the open-source dependencies they ingest, tackling a rapidly expanding attack surface.

U.S. health tech giant Inovalon joins the World Economic Forum, aiming to leverage its massive data platform to combat a looming global health worker shortage.

A new partnership promises to slash security analyst workload by 75% using agentic AI, signaling a major shift in how cybersecurity is managed globally.

New pre-clinical data shows engineered immune cells (iMacrophages) can effectively target and destroy ovarian tumors, offering hope for a new treatment era.

A new IDEO report quantifies how specific workplace behaviors create a $10 billion profit gap, proving that how a company operates is its biggest asset.

Biotech firm Scribe Therapeutics, co-founded by a Nobel laureate, is pioneering a new gene therapy for high cholesterol that silences genes, not cuts them.

With over 80% of AI projects failing, a new diagnostic test from MobiDev aims to help executives understand why and how to salvage their investments.

With its third acquisition in 10 months, Pinnaql, backed by 3 Boomerang Capital, is rapidly building a one-stop-shop for life sciences advisory.

A new system from OSHIMA goes beyond simple defect detection, integrating AI inspection with spreading and cutting for a seamless smart factory workflow.

Justt is the first chargeback firm on the Forbes Fintech 50, showing AI is now crucial for merchants fighting a growing $125 billion problem.

Pair Team's AI 'Flora' joins a new Medicare program to tackle chronic illness by addressing social needs, a bold move in value-based care.